Abstract:Psoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed "Buguzhi" in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatment of osteoporosis, tumors, viruses, bacteria, and inflammation. The present review focuses on the research evidence relating to the properties of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen exerts strong anti-osteoporotic effects via regulation of osteoblast/osteoclast/chondrocyte differentiation or activation due to the participation in multiple molecular mechanisms of the wnt/β-catenin, bone morphogenetic protein (BMP), inositol-requiring enzyme 1 (IRE1)/apoptosis signaling kinase 1 (ASK1)/c-jun N-terminal kinase (JNK) and the Protein Kinase B(AKT)/activator protein-1 (AP-1) axis, and the expression of miR-488, peroxisome proliferators-activated receptor-gamma (PPARγ), and matrix metalloproteinases (MMPs). In addition, the antitumor properties of psoralen are associated with the induction of ER stress-related cell death via enhancement of PERK: Pancreatic Endoplasmic Reticulum Kinase (PERK)/activating transcription factor (ATF), 78kD glucose-regulated protein (GRP78)/C/EBP homologous protein (CHOP), and 94kD glucose-regulated protein (GRP94)/CHOP signaling, and inhibition of P-glycoprotein (P-gp) or ATPase that overcomes multidrug resistance. Furthermore, multiple articles have shown that the antibacterial, anti-inflammatory and neuroprotective effects of psoralen are a result of its interaction with viral polymerase (Pol), destroying the formation of biofilm, and regulating the activation of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin 4/5/6/8/12/13 (IL-4/5/6/8/12/13), GATA-3, acetylcholinesterase (AChE), and the hypothalamic-pituitary-adrenal (HPA) axis. Finally, the toxic effects and mechanisms of action of psoralen have also been reviewed.

Synthesis and Biological Evaluation of Glycosylated Psoralen Derivatives

Synthesis and Antiproliferative Activities of Novel 5'-Schiff-base Group Substituted Psoralen Derivatives

Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea Corylifolia L. Seeds.

Psoralen Derivatives with Enhanced Potency

Anti-tumor effect and hepatotoxicity mechanisms of psoralen

Psoralen: a narrative review of current and future therapeutic uses

Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties

The synthesis and characterization of novel photosensitizer for the photodynamic therapy

Progress in Porphyrins As a Photosensitizing Drug for Photodynamic Therapy

A Review of the Pharmacological Properties of Psoralen

Design, Synthesis and Fungicidal Evaluation of Novel Psoralen Derivatives Containing Sulfonohydrazide or Acylthiourea Moiety.

Design and Synthesis of Novel Water-Soluble Amino Acid Derivatives of Chlorin P6 Ethers As Photosensitizer

Synthesis and Biological Evaluation of Novel Coupling Derivatives of Photosensitizer and 5-fluorouracil as Antineoplastic Agents

Synthesis and evaluation of novel fluorinated hematoporphyrin ether derivatives for photodynamic therapy

Psoralen: A Biologically Important Coumarin with Emerging Applications

Design, Synthesis and Biological Evaluation of Novel 31-Hexyloxy Chlorin E6-Based 152- or 131-Amino Acid Derivatives As Potent Photosensitizers for Photodynamic Therapy.

Synthesis and evaluation of new fluorinated pyropheophorbide-a derivatives for photodynamic therapy

Novel pyropheophorbide a dimers: Synthesis and photobiological evaluation as potent photosensitizers for photodynamic therapy

Water-soluble Porphyrin Photosensitizers Containing Electron-Withdrawing and Electron-Donating Groups for Photodynamic Therapy

Synthesis, Characterization, and Biological Evaluation of a Porphyrin-Based Photosensitizer and Its Isomer for Effective Photodynamic Therapy Against Breast Cancer

Synthesis and evaluation of novel mitochondria-targeted, water-soluble phenoxazine-porphyrins for efficient photodynamic therapy